Veres Gábor

1.

Szabó, G. T., Loganathan, S., Korkmaz-Icöz, S., Balogh, Á., Papp, Z., Brlecic, P., Hegedüs, P., Radovits, T., Karck, M., Merkely, B., Veres, G.: Improvement of Left Ventricular Graft Function Using an Iron-Chelator-Supplemented Bretschneider Solution in a Canine Model of Orthotopic Heart Transplantation.
Int. J. Mol. Sci. 23 (13), 1-14, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

2.

Virok, D. P., Raffai, T., Kókai, D., Paróczai, D., Bogdanov, A., Veres, G., Vécsei, L., Póliska, S., Tiszlavicz, L., Somogyvári, F., Endresz, V., Burián, K.: Indoleamine 2,3-Dioxygenase Activity in Chlamydia muridarum and Chlamydia pneumoniae Infected Mouse Lung Tissues.
Front. Cell. Infect. Microbiol. 9, 1-12, 2019.

doi DEA WoS Scopus

Journal metrics:

Q1 Immunology

Q1 Infectious Diseases

D1 Medicine (miscellaneous)

Q1 Microbiology

Q1 Microbiology (medical)

3.

Tornai, T. I., Tornai, D., Sipeki, N., Tornai, I., Alsulaimani, R., Fechner, K., Roggenbuck, D., Norman, G. L., Veres, G., Pár, G., Pár, A., Szalay, F., Lakatos, P., Antal-Szalmás, P., Papp, M.: Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis.
Sci. Rep. 8 (1), 1-11, 2018.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

4.

Gell, G., Kovács, K., Veres, G., Korponay-Szabó, I., Juhász, A.: Characterization of globulin storage proteins of a low prolamin cereal species in relation to celiac disease.
Sci. Rep. 7 (39876), 1-10, 2017.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

5.

Tornai, T. I., Pályu, E., Vitális, Z., Tornai, I., Tornai, D., Antal-Szalmás, P., Norman, G. L., Shums, Z., Veres, G., Dezsőfi, A., Pár, G., Pár, A., Orosz, P., Szalay, F., Lakatos, P., Papp, M.: Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis.
World J. Gastroenterol. 23 (29), 5412-5421, 2017.

doi DEA

Journal metrics:

Q1 Gastroenterology

Q1 Medicine (miscellaneous)

6.

Müller, K. E., Lakatos, P., Kovács, J. B., Arató, A., Várkonyi, Á., Nemes, É., Tárnok, A., Tóth, G., Papp, M., Sólyom, E., Horváth, Á., Guthy, I., Kovács, M., Veres, G., Hungarian IBD Registry Group (HUPIR): Baseline Characteristics and Disease Phenotype In Inflammatory Bowel Disease.
J. Pediatr. Gastroenterol. Nutr. 62 (1), 50-55, 2016.

doi DEA

Journal metrics:

Q1 Gastroenterology

Q1 Pediatrics, Perinatology and Child Health

7.

Papp, M., Tornai, T. I., Kovács, G., Vitális, Z., Tornai, I., Fechner, K., Roggenbuck, D., Tornai, D., Norman, G. L., Shums, Z., Veres, G., Orosz, P., Lomaby, B., Gervain, J., Pár, G., Pár, A., Lakatos, P., Szalay, F., Antal-Szalmás, P.: Target-specific anti-pancreatic antibodies are frequent in patients with primary sclerosing cholangitis and associated with poor disease outcome.
In: Gut-Liver Interactions: From IBD to NASH - March 11-12, 2016, Congress Innsbruck : Abstracts, Poster Abstracts. Eds.: H. Tilg, A. Kaser, M. P. Manns, G. Szabo, M. Trauner, Karger, Basel, 1-2, 2016.

DEA

8.

Párniczky, A., Czakó, L., Dubravcsik, Z., Farkas, G., Hegyi, P. J., Hritz, I., Kelemen, D., Morvay, Z., Oláh, A., Pap, Á., Sahin-Tóth, M., Szabó, F., Szentkereszty, Z., Szmola, R., Takács, T., Tiszlavicz, L., Veres, G., Szűcs, Á., Lásztity, N.: Gyermekkori pancreatitis: a Magyar Hasnyálmirigy Munkacsoport bizonyítékon alapuló kezelési irányelvei.
Orv. Hetil. 156 (8), 308-325, 2015.

DEA

Journal metrics:

Q3 Medicine (miscellaneous)

9.

Sipeki, N., Dávida, L., Pályu, E., Altorjay, I., Hársfalvi, J., Antal-Szalmás, P., Szabó, Z., Veres, G., Shums, Z., Norman, G. L., Lakatos, P., Papp, M.: Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
World J. Gastroenterol. 21 (22), 6952-6964, 2015.

doi DEA

Journal metrics:

Q1 Gastroenterology

Q1 Medicine (miscellaneous)

10.

Papp, M., Sipeki, N., Tornai, T. I., Altorjay, I., Norman, G. L., Shums, Z., Roggenbuck, D., Fechner, K., Stocker, W., Antal-Szalmás, P., Veres, G., Lakatos, P.: Rediscovery of the anti-pancreatic antibodies and evaluation of their prognostic value in a prospective clinical cohort of Crohn's patients: the importance of specific target antigens (GP2 and CUZD1).
J. Crohns Colitis. 9 (8), 659-668, 2015.

doi DEA

Journal metrics:

D1 Gastroenterology

D1 Medicine (miscellaneous)

11.

Szabó, D., Hosszú, É., Arató, A., Müller, K. E., Béres, N., Lakatos, P., Papp, M., Dezsőfi, A., Szabó, A., Szűcs, D., Veres, G.: Seasonal variability of vitamin D and bone metabolism in infliximab-treated paediatric Crohn's disease.
Dig Liver Dis. 47 (5), 652-657, 2015.

doi DEA

Journal metrics:

Q2 Gastroenterology

Q2 Hepatology

12.

Szabó, D., Kökönyei, G., Arató, A., Dezsőfi, A., Molnár, K., Müller, K. E., Lakatos, P., Papp, M., Lovász, B. D., Golovics, P. A., Cseh, Á., Veres, G.: Autoregressive cross-lagged models of IMPACT-III and Pediatric Crohn's Disease Activity indexes during one year infliximab therapy in pediatric patients with Crohn's disease.
J. Crohns Colitis. 8 (8), 747-755, 2014.

doi DEA

Journal metrics:

Q1 Gastroenterology

D1 Medicine (miscellaneous)

13.

Müller, K. E., Lakatos, P., Papp, M., Veres, G.: Incidence and Paris Classification of Pediatric Inflammatory Bowel Disease.
Gastroenterol. Res. Pract. 2014, 2014.

doi DEA

Journal metrics:

Q2 Gastroenterology

Q2 Hepatology

14.

Kovács, M., Müller, K. E., Papp, M., Lakatos, P., Csöndes, M., Veres, G.: New serological markers in pediatric patients with inflammatory bowel disease.
World J. Gastroenterol. 20 (17), 4873-4882, 2014.

doi DEA

Journal metrics:

Q2 Gastroenterology

Q1 Medicine (miscellaneous)

15.

Veres, G.: Oláh Éva professzor asszonnyal beszélget Veres Gábor.
Gyermekgyógyászat. 65 (6), 370-372, 2014.

DEA

16.

Muller, K., Papp, M., Lakatos, P., Veres, G., Hungarian Pediatric IBD: A nation-wide registry of paediatric inflammatory bowel disease: improvement of diagnostic workup and Paris Classification.
J. Crohns Colitis. 7 (S1), S276-S277, 2013.

DEA

17.

Müller, K. E., Arató, A., Lakatos, P., Papp, M., Veres, G.: Foreign body impaction in the sigmoid colon: a twenty euro bet.
World J. Gastroenterol. 19 (25), 1-3, 2013.

doi DEA

Journal metrics:

Q2 Gastroenterology

Q1 Medicine (miscellaneous)

18.

Müller, K. E., Lakatos, P., Arató, A., Kovács, J. B., Várkonyi, Á., Szűcs, D., Szakos, E., Sólyom, E., Kovács, M., Polgár, M., Nemes, É., Guthy, I., Tokodi, I., Tóth, G., Horváth, Á., Tárnok, A., Csoszánszky, N., Balogh, M., Vass, N., Bodi, P., Dezsőfi, A., Gardos, L., Micskey, É., Papp, M., Cseh, Á., Szabó, D., Vörös, P., Veres, G., Hungarian IBD Registry Group (HUPIR): Incidence, paris classification and follow-up in a nationwide, incident cohort of pediatric patients with inflammatory bowel disease.
J. Pediatr. Gastroenterol. Nutr. 57 (5), 576-582, 2013.

doi DEA

Journal metrics:

Q1 Gastroenterology

Q1 Pediatrics, Perinatology and Child Health

19.

Sziksz, E., Veres, G., Vannay, Á., Prokai, Á., Himer, L., Ónody, A., Korponay-Szabó, I., Reusz, G., Szabó, A., Arató, A., Szebeni, B.: Fokozott hősokk fehérje 72 expresszió gyermekkori coeliakiában.
Gyermekgyógyászat. 62 (2), 30-34, 2011.

DEA

20.

Zákány, J., Farkas, J., Takács, L., Veres, G., Raskó, I.: Detection of a nerve-specific membrane protein on differentiating PCC3/A/1 cells.
Cell Differ. 15 (2-4), 141-145, 1984.

doi DEA

Publication list